May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

May 27, 2021

Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...

April 2021: IMPAACT 2010/VESTED trial evaluates the virological efficacy and safety of ART regimens containing DTG when started in pregnancy

Apr 29, 2021

Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...

Hazardous Alcohol Use, Antiretroviral Therapy Receipt and Viral Suppression in People Living With HIV Who Inject Drugs in the U.S., India, Russia and Vietnam

Nov 16, 2020

Jennifer A Wagman, Adriane Wynn, Mika Matsuzaki, Natalia Gnatienko, Lisa R Metsch, Carlos Del Rio, Daniel J Feaster, Robin M Nance, Bridget M Whitney, Joseph A C Delaney, Shoshana Y Kahana, Heidi M Crane, Redonna K Chandler, Jennifer C Elliott, Frederick...

India